Search Results1-20 of  28

  • 1 / 2
  • NAGAYAMA Sekio ID: 9000000608519

    Taiho Pharmaceutical Co., Ltd. (1996 from CiNii)

    Articles in CiNii:2

    • Pharmacokinetics of S-1-Two way biochemical modulation for enhancing 5-FU delivery into tumor and reducing GI toxicities (1996)
    • 抗ヘルペス剤と抗癌性代謝拮抗物質との薬物相互関係について : アシクロビルとFU系薬剤 (1995)
  • NAGAYAMA Sekio ID: 9000000638224

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (7): Metabolism of Components of S-1 after Administration to Tumor bearing Rats (1997)
  • NAGAYAMA Sekio ID: 9000001427693

    Taiho Pharmaceutical Co., Ltd. (2004 from CiNii)

    Articles in CiNii:1

    • Functional Characterization of Single Nucleotide Polymorphisms with Amino Acid Substitution in CYP1A2, CYP2A6, and CYP2B6 Found in the Japanese Population (2004)
  • NAGAYAMA Sekio ID: 9000002977697

    大鵬薬品工業株式会社代謝分析研究所 (2003 from CiNii)

    Articles in CiNii:15

    • MECHANISM OF LETHAL TOXICITY EXERTED BY SIMULTANEOUS ADMINISTRATION OF THE NEW ANTIVIRAL, SORIVUDINE, AND THE ANTITUMOR AGENT, TEGAFUR (1995)
    • ソリブジンから代謝的に生成する(E)-5-(2-ブロモビニル)ウラシルによるラット肝ジヒドロピリミジンデヒドロゲナ-ゼの不可逆的不活性化のメカニズム (1995)
    • ラットにおけるテガフールとソリブジンの薬物相互作用による毒性発現(1) (1995)
  • NAGAYAMA Sekio ID: 9000013896013

    Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:3

    • INACTIVATION MECHANISM OF HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE BY 5-(2'-BROMOVINYL)URACIL, A METABOLITE OF THE ANTIVIRAL, SORIVUDINE (1997)
    • S-1 のイヌにおける体内動態 - 線形性の検討 - (1997)
    • 新規抗癌剤 TAS-103 の体内動態に関する研究 (1997)
  • NAGAYAMA Sekio ID: 9000016807079

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (2008 from CiNii)

    Articles in CiNii:1

    • Time-dependent Induction of Rat Hepatic CYP1A1 and CYP1A2 Expression after Single-dose Administration of the Anti-angiogenic Agent TSU-68 (2008)
  • NAGAYAMA Sekio ID: 9000021026999

    Articles in CiNii:1

    • Occurrence of autoantibody to protein disulfide isomerase in rats with xenobiotic-induced hepatitis. (1994)
  • NAGAYAMA Sekio ID: 9000021033127

    Articles in CiNii:1

    • Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder. (1994)
  • NAGAYAMA Sekio ID: 9000107314531

    Pharmacokinetics Research Lab., Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (2004 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic Modeling of Species-dependent Enhanced Bioavailability of Trifluorothymidine by Thymidine Phosphorylase Inhibitor (2004)
  • NAGAYAMA Sekio ID: 9000252831234

    Tokushima Research Center, Taiho Pharmaceutical Co., Ltd (1997 from CiNii)

    Articles in CiNii:1

    • INACTIVATION MECHANISM OF HUMAN DIHYDROPYRIMIDINE DEHY DROGENASE BY 5-(2'-BROMOVINYL)URACIL, A METABOLITE OF THE ANTIVIRAL, SORIVUDINE (1997)
  • NAGAYAMA Sekio ID: 9000253261951

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(5): Transfer to Fetus and Milk of Components of S-1 in Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253261957

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Dispositon of Components of New Anti-cancer Drug S-1(4): Distribution of Components of S-1 after Repeated Administration to Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253261964

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(3): Absorption, Excretion of Components of S-1 and Effects on Hepatic Drug Metabolizing Enzyme System after Repeated Administration of S-1 to Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253261972

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(2): Distribution of Components of S-1 after Single Administration to Rats and Protein Binding. (1997)
  • NAGAYAMA Sekio ID: 9000253261980

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(1): Absorption and Excretion of Components of S-1 after Single Administration to Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253262013

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (8): Species Differences, Dose Proportionality. (1997)
  • NAGAYAMA Sekio ID: 9000253262020

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (6): Metabolism of Components of S-1 in Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253262055

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (7): Metabolism of Components of S-1 after Administration to Tumor bearing Rats. (1997)
  • NAGAYAMA Sekio ID: 9000257890149

    Pharmacokinetics Research Lab., Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (2004 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic Modeling of Species-dependent Enhanced Bioavailability of Trifluorothymidine by Thymidine Phosphorylase Inhibitor (2004)
  • NAGAYAMA Sekio ID: 9000257890794

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (2008 from CiNii)

    Articles in CiNii:1

    • Time-dependent Induction of Rat Hepatic CYP1A1 and CYP1A2 Expression after Single-dose Administration of the Anti-angiogenic Agent TSU-68 (2008)
  • 1 / 2
Page Top